Bekhof J, Reimink R, Brand PL Systematic review: insufficient validation of clinical scores for the assessment of acute dyspnoea in wheezing children. Paediatr Respir Rev. 2014 Mar;15(1):98-112. doi: 10.1016/j.prrv.2013.08.004. Epub 2013 Oct 11. Review.
Bellani G, Pesenti A Assessing effort and work of breathing. Curr Opin Crit Care. 2014 Jun;20(3):352-8. doi: 10.1097/MCC.0000000000000089. Review.
Collett PW, Perry C, Engel LA Pressure-time product, flow, and oxygen cost of resistive breathing in humans. J Appl Physiol (1985). 1985 Apr;58(4):1263-72.
Gadomski AM, Scribani MB Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014 Jun 17;(6):CD001266. doi: 10.1002/14651858.CD001266.pub4. Review.
Glezen P, Denny FW Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973 Mar 8;288(10):498-505.
Green M, Brayer AF, Schenkman KA, Wald ER Duration of hospitalization in previously well infants with respiratory syncytial virus infection. Pediatr Infect Dis J. 1989 Sep;8(9):601-5.
Klein M, Reynolds LG Relief of sleep-related oropharyngeal airway obstruction by continuous insufflation of the pharynx. Lancet. 1986 Apr 26;1(8487):935-9.
KRIEGER I, WHITTEN CF WORK OF RESPIRATION IN BRONCHIOLITIS. Am J Dis Child. 1964 Apr;107:386-92.
Lampland AL, Plumm B, Meyers PA, Worwa CT, Mammel MC Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr. 2009 Feb;154(2):177-82. doi: 10.1016/j.jpeds.2008.07.021. Epub 2008 Aug 30.
Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013 Feb;39(2):247-57. doi: 10.1007/s00134-012-2743-5. Epub 2012 Nov 10. Review.
Mayfield S, Bogossian F, O'Malley L, Schibler A High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. J Paediatr Child Health. 2014 May;50(5):373-8. doi: 10.1111/jpc.12509. Epub 2014 Feb 25.
McKiernan C, Chua LC, Visintainer PF, Allen H High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr. 2010 Apr;156(4):634-8. doi: 10.1016/j.jpeds.2009.10.039. Epub 2009 Dec 29.
Numa AH, Williams GD, Dakin CJ The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Respir Crit Care Med. 2001 Jul 1;164(1):86-91.
Ritchie JE, Williams AB, Gerard C, Hockey H Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care. 2011 Nov;39(6):1103-10.
Stokes GM, Milner AD, Groggins RC Work of breathing, intra-thoracic pressure and clinical findings in a group of babies with bronchiolitis. Acta Paediatr Scand. 1981 Sep;70(5):689-94.
Wang EE, Law BJ, Stephens D Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995 Feb;126(2):212-9.
Wing R, James C, Maranda LS, Armsby CC Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care. 2012 Nov;28(11):1117-23. doi: 10.1097/PEC.0b013e31827122a9.
High-Flow Nasal Cannula Flow Titration and Effort of Breathing in the Pediatric Intensive Care Unit
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.